share_log

华康生物医学(08622)完成配售合共3100万股 净筹约318万港元

Huakang Biomedical (08622) completed the placement of a total of 31 million shares to raise approximately HK$3.18 million

Zhitong Finance ·  Mar 21 06:32

Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on March 2, 2024...

Zhitong Finance App News, Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met and completed on March 21, 2024. The placement agent has successfully placed a total of 31 million shares to no less than six undertakers at the placement price of HK$0.104 per share in accordance with the terms and conditions of the placement agreement. The net proceeds from the placement (after deducting commissions and other expenses relating to the placement) are approximately HK$3.18 million, which is intended to be used as general working capital for the Group's operations outside of China.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment